Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.69−0.04 (-1.65%)
Close on Nov 18, 2026Market cap $115.53MP/E –Yield –
Pulmonx revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Pulmonx's revenue for the twelve months ending Jun 30, 2026 was $87.44M, down 3.4% year over year. For fiscal 2025 it was $90.50M, up 8.0% from the year before. The highest annual figure on record is $90.50M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $90.50M | +8.0% |
| FY2024 | Dec 31, 2024 | $83.79M | +22.0% |
| FY2023 | Dec 31, 2023 | $68.68M | +28.0% |
| FY2022 | Dec 31, 2022 | $53.66M | +10.8% |
| FY2021 | Dec 31, 2021 | $48.42M | +47.9% |
| FY2020 | Dec 31, 2020 | $32.73M | +0.4% |
| FY2019 | Dec 31, 2019 | $32.60M | +62.9% |
| FY2018 | Dec 31, 2018 | $20.00M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.76M | -4.6% |
| Q1 FY2026 | Mar 31, 2026 | $20.59M | -8.7% |
| Q4 FY2025 | Dec 31, 2025 | $22.60M | -4.9% |
| Q3 FY2025 | Sep 30, 2025 | $21.50M | +5.5% |
| Q2 FY2025 | Jun 30, 2025 | $23.86M | +14.8% |
| Q1 FY2025 | Mar 31, 2025 | $22.54M | +19.5% |
| Q4 FY2024 | Dec 31, 2024 | $23.77M | +23.3% |
| Q3 FY2024 | Sep 30, 2024 | $20.39M | +15.4% |
| Q2 FY2024 | Jun 30, 2024 | $20.78M | +20.9% |
| Q1 FY2024 | Mar 31, 2024 | $18.85M | +29.7% |
| Q4 FY2023 | Dec 31, 2023 | $19.28M | +25.0% |
| Q3 FY2023 | Sep 30, 2023 | $17.67M | +30.9% |
| Q2 FY2023 | Jun 30, 2023 | $17.19M | +23.3% |
| Q1 FY2023 | Mar 31, 2023 | $14.54M | +34.8% |
| Q4 FY2022 | Dec 31, 2022 | $15.43M | +12.5% |
| Q3 FY2022 | Sep 30, 2022 | $13.50M | +1.8% |
| Q2 FY2022 | Jun 30, 2022 | $13.95M | +14.3% |
| Q1 FY2022 | Mar 31, 2022 | $10.79M | +16.7% |
| Q4 FY2021 | Dec 31, 2021 | $13.71M | +39.5% |
| Q3 FY2021 | Sep 30, 2021 | $13.26M | +25.0% |
| Q2 FY2021 | Jun 30, 2021 | $12.20M | +232.2% |
| Q1 FY2021 | Mar 31, 2021 | $9.24M | +7.3% |
| Q4 FY2020 | Dec 31, 2020 | $9.83M | -5.0% |
| Q3 FY2020 | Sep 30, 2020 | $10.61M | +16.6% |
| Q2 FY2020 | Jun 30, 2020 | $3.67M | -50.1% |
| Q1 FY2020 | Mar 31, 2020 | $8.62M | +49.2% |
| Q4 FY2019 | Dec 31, 2019 | $10.35M | – |
| Q3 FY2019 | Sep 30, 2019 | $9.10M | – |
| Q2 FY2019 | Jun 30, 2019 | $7.37M | – |
| Q1 FY2019 | Mar 31, 2019 | $5.78M | – |
See a number that looks wrong?